FSA compares two equities products: the Allianz Global Equity Growth Fund and the Schroder ISF Global Sustainable Growth Fund.
BNP Paribas receives green light for China wealth management joint venture
The French bank follows in the footsteps of Amundi, Goldman Sachs and others.
Asia ex-Japan households increase securities investments
Bank deposits remain the most dominant asset class though, according to report from Allianz.
The FSA Spy market buzz – 18 March 2022
AB acquires; UBS is hiring; Hang Seng’s changing bestseller; BNP goes for hydrogen; Standard Chartered’s focus list; Deals are down but not out; Kapuściński’s Russian classic; advertising and much more.
The FSA Spy market buzz – 18 February 2022
HSBC is hiring; So is Hang Seng; Allianz’s hedge fund woes; Hang Seng Index makeover; ARK’s bloodbath; M&A exuberance; Amundi’s NFT; Tim Cook’s payday; CPF cash; Putin the bond villain; and much more.
Mutual Fund Top Trumps – Greater China equities
This week FSA presents a quick comparison of two Greater China equities products: the Allianz All China Equity Fund and the BNP Paribas China Equity Classic.
HEAD-TO-HEAD: Allianz versus FSSA
FSA compares two China equity products: the Allianz China A Shares Fund and the FSSA Greater China Growth Fund.
HEAD-TO-HEAD: Allianz versus JP Morgan
FSA compares two Apac equity products: the Allianz Oriental Income Fund and JP Morgan Pacific Equity Fund.
Landmark sale means Allianz first to fully own China life firm
A rule change in early 2021 opened up the China market to foreign insurers.
FSA People Moves (3 November – 9 November 2021)
Eastspring restructures management; Barclays PB builds up Singapore team; Allianz has new Apac CEO; Manulife IM hire bond duo; CS asset management selects Apac interim boss; Robeco boosts sustainable multi asset team.